(19)
(11) EP 3 846 884 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.03.2024 Bulletin 2024/11

(45) Mention of the grant of the patent:
31.01.2024 Bulletin 2024/05

(21) Application number: 19766307.3

(22) Date of filing: 03.09.2019
(51) International Patent Classification (IPC): 
A61M 15/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 15/00; A61M 15/0003; A61M 15/0043; A61M 15/0045; A61M 15/0051; A61M 15/0078
(86) International application number:
PCT/GB2019/052450
(87) International publication number:
WO 2020/049288 (12.03.2020 Gazette 2020/11)

(54)

MEDICAMENT DELIVERY DEVICE AND METHODS

MEDIKAMENTENABGABEVORRICHTUNG UND VERFAHREN

DISPOSITIF ET PROCÉDÉS D'ADMINISTRATION DE MÉDICAMENT

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 03.09.2018 GB 201814300

(43) Date of publication of application:
14.07.2021 Bulletin 2021/28

(73) Proprietor: TTP PLC
Melbourn SG8 6HQ (GB)

(72) Inventors:
  • COTTENDEN, David
    Royston, Hertfordshire SG8 6EE (GB)
  • WANG, Jianye
    Royston, Hertfordshire SG8 6EE (GB)
  • YOUNG, Duncan
    Royston, Hertfordshire SG8 6EE (GB)
  • CHEUNG, Desmond
    Royston, Hertfordshire SG8 6EE (GB)
  • WADDELOW, Simon
    Royston, Hertfordshire SG8 6EE (GB)
  • MCDERMENT, Iain
    Royston, Hertfordshire SG8 6EE (GB)
  • SELBY, Rob
    Royston, Hertfordshire SG8 6EE (GB)

(74) Representative: Gill Jennings & Every LLP 
The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)


(56) References cited: : 
WO-A1-03/061743
WO-A1-2010/133323
 WO-A1-03/061744
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).